02/05/2015 - 11:16am

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

02/03/2015 - 3:25pm

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

02/03/2015 - 3:06pm

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 

 

02/03/2015 - 12:54pm

New York Attorney General Eric Schneiderman on Monday called on four major retailers to stop selling store-brand herbal supplement products in New York that could not be verified to contain the labeled substance by using what the industry describes as a questionable testing method — DNA barcoding.

02/02/2015 - 5:48pm

A proposal in the Budget of the U.S. government, fiscal year 2016 calls for an increase in retail pharmacy prescription drug co-pays.

02/02/2015 - 10:43am

The Food and Drug Administration announced that it has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults, making it the first FDA-approved medicine to treat this condition.

 

01/30/2015 - 2:13pm

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

01/30/2015 - 12:51pm

The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology released a draft roadmap toward the safe and secure exchange and use of electronic health information.

 

01/29/2015 - 5:52pm

On the heels of Wednesday’s news that the U.S. House of Representatives introduced bipartisan legislation that would formally designate pharmacists as healthcare providers under Medicare Part B, the U.S. Senate has followed suit with a companion bill.